Literature DB >> 25246305

Comparison of Effects of Different Dexmedetomidine and Chloral Hydrate Doses Used in Sedation on Electroencephalography in Pediatric Patients.

Hakan Gumus1, Ayşe Kacar Bayram2, Hatice Gamze Poyrazoglu2, Dilek Gunay Canpolat3, Huseyin Per2, Mehmet Canpolat2, Karamehmet Yildiz3, Sefer Kumandas2.   

Abstract

The aim of this study was to compare the efficacy and safety of different oral chloral hydrate and dexmedetomidine doses used for sedation during electroencephalography (EEG) in children. One hundred sixty children aged 1 to 9 years with American Society of Anesthesiologists physical status I-II who were uncooperative during EEG recording or who were referred to our electrodiagnostic unit for sleep EEG were included to the study. The patients were randomly assigned into 4 groups. In groups D1 and D2, patients received oral dexmedetomidine doses of 2 and 3 µg/kg, respectively. In group C1 and C2, patients received oral chloral hydrate doses of 50 and 100 mg/kg, respectively. The induction time was significantly shorter in group C2 compared with other groups (P = .000). The rate of adverse effects was significantly higher in group C2 compared with the dexmedetomidine groups (D1 and D2; P = .004). In conclusion, dexmedetomidine can be used safely for sedation during EEG in children.
© The Author(s) 2014.

Entities:  

Keywords:  chloral hydrate; dexmedetomidine; electroencephalography

Mesh:

Substances:

Year:  2014        PMID: 25246305     DOI: 10.1177/0883073814549582

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

Review 1.  Triclofos Sodium for Pediatric Sedation in Non-Painful Neurodiagnostic Studies.

Authors:  Eytan Kaplan; Ayman Daka; Avichai Weissbach; Dror Kraus; Gili Kadmon; Rachel Milkh; Elhanan Nahum
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

Review 2.  Intranasal Dexmedetomidine for Procedural Sedation in Children, a Suitable Alternative to Chloral Hydrate.

Authors:  Giorgio Cozzi; Stefania Norbedo; Egidio Barbi
Journal:  Paediatr Drugs       Date:  2017-04       Impact factor: 3.022

3.  EEG for children with complex febrile seizures.

Authors:  Pankaj B Shah; Saji James; Sivaprakasam Elayaraja
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09

Review 4.  Chloral hydrate as a sedating agent for neurodiagnostic procedures in children.

Authors:  Choong Yi Fong; Chee Geap Tay; Lai Choo Ong; Nai Ming Lai
Journal:  Cochrane Database Syst Rev       Date:  2017-11-03

5.  Analysis of Risk Factors for Chloral Hydrate Sedative Failure with Initial Dose in Pediatric Patients: a Retrospective Analysis.

Authors:  Yu Cui; Langtao Guo; Qixia Mu; Lu Kang; Qin Chen; Qunying Wu; Yani He; Min Tang
Journal:  Paediatr Drugs       Date:  2022-05-21       Impact factor: 3.022

Review 6.  Chloral hydrate as a sedating agent for neurodiagnostic procedures in children.

Authors:  Choong Yi Fong; Wei Kang Lim; Limin Li; Nai Ming Lai
Journal:  Cochrane Database Syst Rev       Date:  2021-08-16

Review 7.  EEG for children with complex febrile seizures.

Authors:  Pankaj B Shah; Saji James; S Elayaraja
Journal:  Cochrane Database Syst Rev       Date:  2017-10-07

8.  Efficacy of chloral hydrate oral solution for sedation in pediatrics: a systematic review and meta-analysis.

Authors:  Zhe Chen; Mao Lin; Zongyao Huang; Linan Zeng; Liang Huang; Dan Yu; Lingli Zhang
Journal:  Drug Des Devel Ther       Date:  2019-07-31       Impact factor: 4.319

9.  ED50 of Intranasal Dexmedetomidine Sedation for Transthoracic Echocardiography in Children with or without a History of Cardiac Surgery for Cyanotic Congenital Heart Disease.

Authors:  HongBin Gu; YunAn Song; Jie Bai
Journal:  Biomed Res Int       Date:  2020-12-12       Impact factor: 3.411

10.  Comparison of dexmedetomidine with chloral hydrate as sedatives for pediatric patients: A systematic review and meta-analysis.

Authors:  Xianghong Lian; Yunzhu Lin; Ting Luo; Hongbo Yuan; Yuan Chen
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.